Home > Insider Trading > Filing (0001493152-22-001313)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1119643	Nutra Pharma Corp	NPHC	Medicinal Chemicals & Botanical Products (2833)	912021600

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1266490	J Rik Deitsch	1537 Nw 65Th Avenue Plantation FL 33313	President, Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Series B Preferred Stock	Acquisiton	2021-11-15	3,000,000	$0.00	3,000,000	No	4	P	Direct
Series B Preferred Stock	Acquisiton	2021-11-15	9,000,000	$0.00	12,000,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	43,298,859	Direct

Footnotes

Series B preferred stock have no right of conversion to shares of common stock. Each share of Series B preferred stock is entitled to vote with the Corporation's common stock as a single class on all matters submitted to common stock holders to vote. Each share of Series B Preferred Stock is entitled to one thousand votes per share.
3,000,000 shares of Series A Preferred Stock held by Mr. Deitsch were exchanged for an equal number of Series B Preferred Stock of the Company pursuant to a share exchange agreement between Rik Deitsch and the Company.
9,000,000 shares of Series B Preferred Stock were issued in satisfaction of corporate debt owed by the Company to Mr. Deitsch pursuant to a resolution adopted by the board of directors of the Company.